Lomitapide Mesylate: Medgend

Lomitapide Mesylate FDA Approved Drugs

JUXTAPID [Lomitapide Mesylate^{C₃₉H₃₇F₆N₃O₂CH₄O₃S}]

eq 10mg base (oral capsule)

eq 20mg base (oral capsule)

eq 30mg base (oral capsule)

eq 40mg base (oral capsule)

eq 5mg base (oral capsule)

eq 60mg base (oral capsule)

Aegerion^{Dec 21, 2012}

A dosing regimen for the treatment of hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia using at least three step-wise increasing doses.
A dosing regimen for the treatment of hypercholesterolemia and hyperlipidemia in patients with homozygous familial hypercholesterolemia using at least three step-wise increasing doses.
Treatment of hypercholesterolemia by decreasing the amount or activity of microsomal triglyceride transfer protein in patients with homozygous familial hypercholesterolemia.
Treatment of hypercholesterolemia, hyperlipidemia and hyperlipoproteinemia in patients with homozygous familial hypercholesterolemia.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.